Isolation and characterization of mesenchymal progenitors derived from the bone marrow of goats native from northeastern Brazil

PURPOSE: To characterize bone marrow progenitors cells grown in vitro, using native goats from northeastern Brazil as animal model. METHODS: Ten northeastern Brazil native goats of both genders were used from the Piauí Federal University Agricultural Science Center's (UFPI) - Goat Farming Sector. Bone marrow aspirates where taken from the tibial ridge and seeded on culture plates for isolation, expansion and Flow Cytometry (expression markers - Oct-3/4, PCNA, Ck-Pan, Vimentina, Nanog). RESULTS: Progenitor cells showed colonies characterized by the presence of cell pellets with fibroblastoid morphology. Cell confluence was taken after 14 days culture and the non-adherent mononuclear cell progressive reduction. After the first passage, 94.36% cell viability was observed, starting from 4.6 x 106 cell/mL initially seeded. Cells that went through flow cytometry showed positive expression for Oct-3/4, PCNA, Ck-Pan, Vimentina, and Nanog. CONCLUSIONS: Bone marrow progenitor isolated of native goats from northeastern Brazil showed expression markers also seen in embryonic stem cells (Oct-3/4, Nanog), markers of cell proliferation (PCNA) and markers for mesenchymal cells (Vimentina and Ck-pan), which associated to morphological and culture growth features, suggest the existence of a mesenchymal stem cell (MSC) population in the goat bone marrow stromal cells studied. .

Inmunohistochemical expression of PCNA, p53 and bcl-2 in pleomorphic adenomas / Expresión inmunohistoquímica de PCNA, p53 y bcl-2 en adenomas pleomórficos

The aim of the study was to determine the immunohistochemical expression of the PCNA, p53 and bcl-2 proteins in pleomorphic adenomas. Nineteen specimens of pleomorphic adenomas were selected for analysis by the streptavidin-biotin-peroxidase method with antibodies againstp53, PCNA and bcl-2 proteins. It was observed weak labeling for p53 in 12 cases (63.1 percent) andforPCNA in 8 (42.1 percent). With respect to the bcl-2 labeling index, o no expression of this protein was detected in 12 cases, corresponding to 63.1 percent of the sample. Based on these findings, it was concluded that p53 and PCNA can favour the proliferative activity of pleomorphic adenomas, whereas bcl-2 probably does not effectively participate in the pathogenesis of this tumor.

El objetivo del estudio fue determinar la expresión inmmunohistoquímica de las proteínas PCNA, p53 y bcl-2 en adenomas pleomórficos. Fueron seleccionados 19 especímenes de adenomas pleomórficos para análisis a través del método de la estreptavidina-biotina-peroxidasa con anticuerpos contra las proteínas p53, PCNA y bcl-2. Fue observada leve marcación para p53 en 12 casos (63,1 por ciento) y para PCNA en 8 (42,1 por ciento). Con relación al índice de marcación para bcl-2, ono fue detectada en 12 casos (63,1 por ciento) expresión de esta proteína. En base a los resultados, se concluyó que las proteínas p53 y PCNA pueden favorecer la actividad proliferativa de adenomas pleomórficos, y por otro lado, la bcl-2 probablemente ono participaría efectivamente de la patogenia de este tumor.

Antígeno nuclear de proliferación celular en cáncer de cuello uterino y lesiones precursoras / Nuclear antigen of cellular proliferation in uterine cervix cancer and precursor lesions

The aim of this study was to study the degree of cellular proliferation quantifying the immunohistochemical expression of the proliferating cell nuclear antigen. We assessed paraffin embedded samples od 25 infiltrating epidermoid cervical carcinomas, 76 precursor lesions (34 of low and 42 of high grade), 29 normal and 13 metaplastic epidermoid epithelia. Mean values of proliferating cell nuclear antigen expression were 13.7 percent in normal epithelia, 15.7 percent in epidermoid metaplasia, 37.1 percent in low grade precursor lesions (35.3 percent in condilomas and 38.8 percent in mild dysplasia), 48.7 percent in high grade lesions (47.9 percent in moderate dysplasia, 50.5 percent in severe dysplasia and 50 percent in carcinoma in situ) and 54.7 percent in infiltrating carcinoma. There were differences in proliferating cell nuclear antigen expression and mitotic index between low grade precursor lesions and high grade lesions and infiltrating carcinoma. No correlation was observed between mitotic index and proliferating cell nuclear antigen expression. We conclude that infiltrating epidermoid cervical carcinoma and its precursor lesions have a high level of proliferative activity, demonstrated by a high percentage of cells in active phases of the cellular cycle

Factores pronósticos en cáncer de mama / Prognostic factors in breast cancer

La histología permanece como el pilar básico del diagnóstico del cáncer de mama determinando el tipo histológico del tumor, su tamñano y compromiso linfático, añadiendo también otros importantes datos que se relacionan con el pronóstico, como el grado histológico y nuclear. Sin embargo, las expectativas pronósticas en cuanto a diagnóstico y clasificación han cambiado notablemente en los últimos años y han surgido nuevas alternativas terapéuticas que han impulsado el estudio del cáncer de mama a nivel molecular, aportando de esta forma nuevos mediadores pronósticos que podrán en el futuro llenar las expectativas de Blamey (The 1989 Walter Hubert Lecture) "...el desafío que ahora enfrentamos, es definir la naturaleza individual del cáncer de mama en cada paciente, en lugar de considerar un tipo de tratamiento como adecuado para todos los tumores. Aquí es donde la biología tumoral ha llegado a ser ciencia predominante"